SCHEMBL18398531

SCHEMBL18398531

CCc1cc(F)ccc1CNc1cc2c(ncn2C)c(N)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.36
▸ TLR7 Q9NYK1 8/20 0.35
▸ IKBKB O14920 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ KCNQ3 O43525 1/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398609 0.84 TLR7 (0.32) LMNATLR7ABCB11CDK1
SCHEMBL18398296 0.83 JAK2 (0.37) LMNATLR7IKBKBHRH4ALOX15
SCHEMBL18409422 0.77 CDK1 (0.42) TLR7CDK1SMN1; SMN2CCNE1CDK2
SCHEMBL18398421 0.77 JAK2 (0.35) LMNAIKBKBABCB11CDK1
SCHEMBL18398339 0.75 HRH4 (0.35) LMNATLR7HRH4CYP1A2CYP3A4
SCHEMBL18398366 0.75 LMNA (0.36) LMNATLR7IKBKBKCNH2
SCHEMBL18409182 0.70 CDK1 (0.42) IKBKBCDK1CCNE1CDK2
SCHEMBL18398295 0.69 MAP2K2 (0.40) LMNAABCB11KCNH2PKMP2RX7
SCHEMBL18398495 0.69 MAPT (0.43) LMNAALOX15HSD17B10GAACYP1A2
SCHEMBL18398397 0.69 JAK2 (0.49) LMNAABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback